Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction-Reference-Cited by-同舟云学术

Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction

Published:2017-04 Issue:7 Volume:195 Page:881-888
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Martinez Fernando J.¹²,Vestbo Jørgen³,Anderson Julie A.⁴,Brook Robert D.²,Celli Bartolome R.⁵,Cowans Nicholas J.⁶,Crim Courtney⁷,Dransfield Mark⁸,Kilbride Sally⁴,Yates Julie⁷,Newby David E.⁹,Niewoehner Dennis¹⁰,Calverley Peter M. A.¹¹

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, New York

2. University of Michigan Health System, Ann Arbor, Michigan

3. Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre, The University of Manchester and South Manchester, Manchester, United Kingdom

4. Research & Development, GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom

5. Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

6. Veramed Ltd., Twickenham, United Kingdom

7. Research & Development, GlaxoSmithKline, Research Triangle Park, North Carolina

8. University of Alabama Birmingham, Birmingham, Alabama

9. Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

10. University of Minnesota, Minneapolis, Minnesota; and

11. University of Liverpool, Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, United Kingdom

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference35 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2. Executive Summary

3. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management

4. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials;Thorax;2023-04-03

2. The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset;International Journal of Chronic Obstructive Pulmonary Disease;2022-08

3. International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials;American Journal of Respiratory and Critical Care Medicine;2022-07-01

4. The potential of erdosteine to reduce the rate of exacerbations of chronic obstructive pulmonary disease;PULMONOLOGIYA;2022-05-01

5. Asthma-COPD Overlap;Current Pulmonology Reports;2022-03